Monitoring the adverse profile of atenolol--a collaborative study

Atenolol, a cardio selective beta-adrenergic blocker, frequently prescribed in various cardiac ailments, has not been thoroughly investigated for its adverse reaction profile in Indian patient. The present ADR monitoring study which was open, prospective and collaborative was therefore planned. A to...

Full description

Saved in:
Bibliographic Details
Published in:Indian journal of physiology and pharmacology 1993-07, Vol.37 (3), p.213
Main Authors: Garg, K C, Singhal, K C, Kumar, S
Format: Article
Language:English
Subjects:
Atenolol - adverse effects
Atenolol - therapeutic use
Cardiovascular Diseases - complications
Cardiovascular Diseases - drug therapy
Humans
Middle Aged
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 3
container_start_page 213
container_title Indian journal of physiology and pharmacology
container_volume 37
creator Garg, K C
Singhal, K C
Kumar, S
description Atenolol, a cardio selective beta-adrenergic blocker, frequently prescribed in various cardiac ailments, has not been thoroughly investigated for its adverse reaction profile in Indian patient. The present ADR monitoring study which was open, prospective and collaborative was therefore planned. A total of 440 patients with various heart disease were enrolled after a strict inclusion and exclusion criteria from Maulana Azad Medical College, New Delhi and J.N. Medical College, Aligarh. fifteen patients dropped out leaving 435 for final analysis. Cold extremities occurred in 1.18% headache and dizziness in 1.41% breathlessness in 0.94% oedema in 0.70% and bradycardia in 0.47%. Adverse drug reaction in our study were less than those reported from Western countries. Better patient selection, optimal dose could have reduced the frequency of ADR in the present study. Racial factor and season might be operating to bring down ADR to atenolol in Indian patients.
format article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_8276498</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>8276498</sourcerecordid><originalsourceid>FETCH-LOGICAL-p121t-31eacf4943ea170d1d7feee8810b28d87c1642ce4991a08c02a1657bb2731f1a3</originalsourceid><addsrcrecordid>eNotj8tqAyEUQF20pGnSTyj4A4JXZ0ZdhtAXpHTTrsOd8ZpOMeOgJpC_b6FZnd3hnBu2lBKcaBvn7th9KT9SttZqt2ALq0zXOLtkm_c0jTXlcTrw-k0c_ZlyIT7nFMZIPAWOlaYUUxQC-ZBixD5lrOOZeKknf1mz24Cx0MOVK_b1_PS5fRW7j5e37WYnZlBQhQbCITSu0YRgpAdvAhFZC7JX1lszQNeogf5iAaUdpELoWtP3ymgIgHrFHv-986k_kt_PeTxivuyvK_oXlpBEiA</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Monitoring the adverse profile of atenolol--a collaborative study</title><source>Freely Accessible Journals</source><creator>Garg, K C ; Singhal, K C ; Kumar, S</creator><creatorcontrib>Garg, K C ; Singhal, K C ; Kumar, S</creatorcontrib><description>Atenolol, a cardio selective beta-adrenergic blocker, frequently prescribed in various cardiac ailments, has not been thoroughly investigated for its adverse reaction profile in Indian patient. The present ADR monitoring study which was open, prospective and collaborative was therefore planned. A total of 440 patients with various heart disease were enrolled after a strict inclusion and exclusion criteria from Maulana Azad Medical College, New Delhi and J.N. Medical College, Aligarh. fifteen patients dropped out leaving 435 for final analysis. Cold extremities occurred in 1.18% headache and dizziness in 1.41% breathlessness in 0.94% oedema in 0.70% and bradycardia in 0.47%. Adverse drug reaction in our study were less than those reported from Western countries. Better patient selection, optimal dose could have reduced the frequency of ADR in the present study. Racial factor and season might be operating to bring down ADR to atenolol in Indian patients.</description><identifier>ISSN: 0019-5499</identifier><identifier>PMID: 8276498</identifier><language>eng</language><publisher>India</publisher><subject>Atenolol - adverse effects ; Atenolol - therapeutic use ; Cardiovascular Diseases - complications ; Cardiovascular Diseases - drug therapy ; Humans ; Middle Aged</subject><ispartof>Indian journal of physiology and pharmacology, 1993-07, Vol.37 (3), p.213</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8276498$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Garg, K C</creatorcontrib><creatorcontrib>Singhal, K C</creatorcontrib><creatorcontrib>Kumar, S</creatorcontrib><title>Monitoring the adverse profile of atenolol--a collaborative study</title><title>Indian journal of physiology and pharmacology</title><addtitle>Indian J Physiol Pharmacol</addtitle><description>Atenolol, a cardio selective beta-adrenergic blocker, frequently prescribed in various cardiac ailments, has not been thoroughly investigated for its adverse reaction profile in Indian patient. The present ADR monitoring study which was open, prospective and collaborative was therefore planned. A total of 440 patients with various heart disease were enrolled after a strict inclusion and exclusion criteria from Maulana Azad Medical College, New Delhi and J.N. Medical College, Aligarh. fifteen patients dropped out leaving 435 for final analysis. Cold extremities occurred in 1.18% headache and dizziness in 1.41% breathlessness in 0.94% oedema in 0.70% and bradycardia in 0.47%. Adverse drug reaction in our study were less than those reported from Western countries. Better patient selection, optimal dose could have reduced the frequency of ADR in the present study. Racial factor and season might be operating to bring down ADR to atenolol in Indian patients.</description><subject>Atenolol - adverse effects</subject><subject>Atenolol - therapeutic use</subject><subject>Cardiovascular Diseases - complications</subject><subject>Cardiovascular Diseases - drug therapy</subject><subject>Humans</subject><subject>Middle Aged</subject><issn>0019-5499</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><recordid>eNotj8tqAyEUQF20pGnSTyj4A4JXZ0ZdhtAXpHTTrsOd8ZpOMeOgJpC_b6FZnd3hnBu2lBKcaBvn7th9KT9SttZqt2ALq0zXOLtkm_c0jTXlcTrw-k0c_ZlyIT7nFMZIPAWOlaYUUxQC-ZBixD5lrOOZeKknf1mz24Cx0MOVK_b1_PS5fRW7j5e37WYnZlBQhQbCITSu0YRgpAdvAhFZC7JX1lszQNeogf5iAaUdpELoWtP3ymgIgHrFHv-986k_kt_PeTxivuyvK_oXlpBEiA</recordid><startdate>199307</startdate><enddate>199307</enddate><creator>Garg, K C</creator><creator>Singhal, K C</creator><creator>Kumar, S</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>199307</creationdate><title>Monitoring the adverse profile of atenolol--a collaborative study</title><author>Garg, K C ; Singhal, K C ; Kumar, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p121t-31eacf4943ea170d1d7feee8810b28d87c1642ce4991a08c02a1657bb2731f1a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Atenolol - adverse effects</topic><topic>Atenolol - therapeutic use</topic><topic>Cardiovascular Diseases - complications</topic><topic>Cardiovascular Diseases - drug therapy</topic><topic>Humans</topic><topic>Middle Aged</topic><toplevel>online_resources</toplevel><creatorcontrib>Garg, K C</creatorcontrib><creatorcontrib>Singhal, K C</creatorcontrib><creatorcontrib>Kumar, S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Indian journal of physiology and pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Garg, K C</au><au>Singhal, K C</au><au>Kumar, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Monitoring the adverse profile of atenolol--a collaborative study</atitle><jtitle>Indian journal of physiology and pharmacology</jtitle><addtitle>Indian J Physiol Pharmacol</addtitle><date>1993-07</date><risdate>1993</risdate><volume>37</volume><issue>3</issue><spage>213</spage><pages>213-</pages><issn>0019-5499</issn><abstract>Atenolol, a cardio selective beta-adrenergic blocker, frequently prescribed in various cardiac ailments, has not been thoroughly investigated for its adverse reaction profile in Indian patient. The present ADR monitoring study which was open, prospective and collaborative was therefore planned. A total of 440 patients with various heart disease were enrolled after a strict inclusion and exclusion criteria from Maulana Azad Medical College, New Delhi and J.N. Medical College, Aligarh. fifteen patients dropped out leaving 435 for final analysis. Cold extremities occurred in 1.18% headache and dizziness in 1.41% breathlessness in 0.94% oedema in 0.70% and bradycardia in 0.47%. Adverse drug reaction in our study were less than those reported from Western countries. Better patient selection, optimal dose could have reduced the frequency of ADR in the present study. Racial factor and season might be operating to bring down ADR to atenolol in Indian patients.</abstract><cop>India</cop><pmid>8276498</pmid></addata></record>
fulltext fulltext
identifier ISSN: 0019-5499
ispartof Indian journal of physiology and pharmacology, 1993-07, Vol.37 (3), p.213
issn 0019-5499
language eng
recordid cdi_pubmed_primary_8276498
source Freely Accessible Journals
subjects Atenolol - adverse effects
Atenolol - therapeutic use
Cardiovascular Diseases - complications
Cardiovascular Diseases - drug therapy
Humans
Middle Aged
title Monitoring the adverse profile of atenolol--a collaborative study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T20%3A07%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Monitoring%20the%20adverse%20profile%20of%20atenolol--a%20collaborative%20study&rft.jtitle=Indian%20journal%20of%20physiology%20and%20pharmacology&rft.au=Garg,%20K%20C&rft.date=1993-07&rft.volume=37&rft.issue=3&rft.spage=213&rft.pages=213-&rft.issn=0019-5499&rft_id=info:doi/&rft_dat=%3Cpubmed%3E8276498%3C/pubmed%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p121t-31eacf4943ea170d1d7feee8810b28d87c1642ce4991a08c02a1657bb2731f1a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/8276498&rfr_iscdi=true